Please enable JavaScript.
Coggle requires JavaScript to display documents.
NUR2125: Pathology Muscoskeletal, Genitourinary system, NUR2125:…
-
Genitourinary system
-
Acute kidney disease
Consist of broad spectrum of kidney diseases, from nior changes in renal function to complete renal failure requiring renal replacement therapy
-
-
-
-
Classification systems
RIFLE classification system
Risk of injury, Injury, Failure, Loss of function, End stage kidney disease
1st three, severity
last 2 stages: patient outcomes
-
-
Azotemia: laboratory results
Very severe azotemia: uraemia (can see clinical effects, clinical manifestations)
Risk factors
-
Pre-existing conditions: renal/cardio problems, diabetes, hypertension, cancer
Types of AKI
Intrinsic/intra-renal: kidney blood vessels, tubules, glomeruli or interstitium (Disorders that disrupt the kidney/within the kidney)
Nephrotoxic insult: use of contrast media from imaging scans (Renal vasoconstriction, direct tubular damage) Rich blood supply and ability to concentrate toxins
-
-
-
-
-
-
Management
-
Nursing management
Monitor: vital signs, daily weight, consciousness, urine (and its characteristics)
Lab: BUN, creatine, electrolyte
Monitor urinalysis for protein level, signs of infection
-
-
-
UTI
Risk factors
Women: shorter urethra (but older, become equal)
-
-
Diabetes mellitus
-
High glucose levels, increase risk of UTI
Immunocomrpomised
Body measures are not working:
Washout (micturition)
Physical barrier
Indigeneous proteins
Inflammatory response
-
Ascending, from bladder to kidneys
-
-
-
-
Management
-
Nursing management
-
Assessment
History, sign and symptom
Patient frequency, urgency and hesitancy and changes in urine
-
-
Chronic kidney disease
Manifestation
-
Stages
-
-
3: symptoms start to appear, treatment needed
-
-
Complication
- Hypocalcemia
- Anemia
- Hyperphosphotemia
- Metabolic acidosis
- Mineral and bone disorders
- Volume overload
-
Fluid electrolyte imbalance: sodium, potassium intake restriction
Hypertension/cardio disease: BP goal <130/80mmHg, ACE + antiogensin II receptor blocker, statins to decrease dyslipidemia
Bone and mineral disorders: Vitamin D, Calcimimetics (suppress PTH)
-
-
Risk factors
-
Ethnicity, family history of CKD
-
Management
Treatment
Complex, requires multidisplinary approach
-
Dialysis
Peritoneal
Continuous Ambulatory Peritoneal Dialysis (CAPD) and Continuous Cycling Peritoneal Dialysis (CCPD) can be done at home
-
-
-
Nursing management
-
-
Monitor vitals, Intake and output
-
-
-
-
-